A major clinical trial found that one in five people with chronic hepatitis B could control the virus without further ...

The sneaky virus poses serious health threats if it goes on to become a chronic disease. Clinical trial results suggest a new drug may cure 1 in 5 of those cases.

An alarming new report has found liver cancer deaths have risen from 1.6 deaths per 100,000 people in the 1980s to 5.1 per 100,000 in 2018–2022.

Hepatitis B virus-induced hepatocellular carcinoma (HCC) remains a major global health burden, and new therapeutic and diagnostic approaches are urgently needed. Emerging research highlights the ...

James Kang moved to Milpitas from South Korea in his early 20s with his parents and younger sibling, to a diverse community that included Korean churches, grocers, restaurants, media and traditional ...

Most people recover from the infection, but it poses great risks for those who don’t. A new drug may cure 1 in 5 of these ...

A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver ...

Hepatitis B virus (HBV) infection is known to be associated with the risk of hepatocellular carcinoma (HCC), but how and why they are connected remains unknown. Researchers from Mass General Brigham ...

(A) Mortality number of LCHB, (B) Mortality number of LCAL. LCHB, Liver cancer due to hepatitis B; LCAL, Liver cancer due to alcohol use. In 2021, the global and Chinese death counts and ...

As we mark World Hepatitis Day, WHO calls on governments and partners to urgently accelerate efforts to eliminate viral hepatitis as a public health threat and reduce liver cancer deaths. Every 30 ...

Roche Diagnostics joins as a key strategic collaborator in a multi-sectoral partnership led by The Task Force for Global ...

Nigerians have been urged to equip themselves with basic knowledge about the causes and symptoms of hepatitis and adopt preventive measures as part of their daily lives. Project PINK BLUE emphasised ...